Immunogen Design: The antibody was raised against a recombinant YDL162C protein expressed in S. cerevisiae, ensuring specificity for the endogenous target .
Species Reactivity: Validated exclusively in the S288c yeast strain, with no cross-reactivity reported for other fungal species or mammalian systems .
Western Blot: Detects a single band at the expected molecular weight (~35 kDa) in yeast lysates .
ELISA: Demonstrated linear detection range of 0.1–10 ng/mL for purified YDL162C protein .
YDL162C is an uncharacterized ORF in yeast. This antibody facilitates:
Protein Localization: Subcellular tracking via immunofluorescence (IF).
Expression Profiling: Quantifying YDL162C under stress conditions (e.g., heat shock, nutrient deprivation).
Interaction Networks: Co-immunoprecipitation (Co-IP) to identify binding partners.
Sample Preparation: Requires trichloroacetic acid (TCA) extraction for WB to preserve protein integrity .
Controls: Include ΔYDL162C knockout strains to confirm signal specificity .
Lot Testing: Each batch undergoes:
Avoid freeze-thaw cycles; aliquot upon receipt.
Optimize dilution empirically (recommended starting range: 1:500–1:2,000 for WB).
YDL162C is an uncharacterized open reading frame (ORF) in Saccharomyces cerevisiae (baker's yeast). Studying this protein contributes to our understanding of yeast biology, potentially revealing novel functions within cellular pathways. The antibody against YDL162C provides a valuable tool for detecting, quantifying, and localizing this protein within yeast cells, enabling researchers to investigate its expression patterns, subcellular localization, and potential binding partners.
The YDL162C antibody (product code CSB-PA619583XA01SVG) is a polyclonal antibody raised in rabbits against recombinant YDL162C protein expressed in S. cerevisiae strain ATCC 204508/S288c. It is provided in liquid form, non-conjugated, with a storage buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS (pH 7.4). The antibody has been purified using antigen affinity methods and corresponds to UniProt accession number Q12307 .
The YDL162C antibody has been specifically validated for:
Western blotting: Detects a single band at approximately 35 kDa in yeast lysates
ELISA: Demonstrates a linear detection range of 0.1–10 ng/mL for purified YDL162C protein
Immunofluorescence (IF): Enables subcellular localization studies
These validated applications make the antibody suitable for multiple experimental approaches in yeast biology research.
Upon receipt, the YDL162C antibody should be stored at -20°C or preferably -80°C for optimal stability. The antibody maintains activity for up to 24 months when stored at -80°C. To preserve antibody integrity, it is critical to avoid repeated freeze-thaw cycles by preparing small aliquots upon initial receipt .
For optimal results in Western blotting applications, trichloroacetic acid (TCA) extraction is recommended for sample preparation to preserve protein integrity. This method effectively prevents proteolysis during extraction, which is particularly important when working with yeast proteins. The recommended antibody dilution range for Western blotting is 1:500–1:2,000, though optimal dilution should be determined empirically for each experimental setup.
When working with the YDL162C antibody, the following controls are essential for experimental validation:
Primary control: Include ΔYDL162C knockout strains to confirm signal specificity
Loading control: Use established yeast housekeeping proteins (e.g., actin, GAPDH) to normalize protein levels
Concentration gradient: Test antibody performance across multiple dilutions to optimize signal-to-noise ratio
These controls ensure the reliability and reproducibility of experimental results while confirming the specificity of the detected signal.
The YDL162C antibody demonstrates a linear detection range of 0.1–10 ng/mL in ELISA applications. For optimal results:
Coating concentration: Titrate antigen coating concentration (typically 1-10 μg/mL)
Blocking buffer: Use 1-5% BSA in PBS to minimize background
Antibody concentration: Start with manufacturer's recommended dilution (typically 1:500-1:2,000)
Incubation conditions: Optimize both temperature (4°C-25°C) and duration (1-12 hours)
Detection system: Select appropriate secondary antibody and substrate combination based on desired sensitivity
Systematic optimization of these parameters will enhance assay sensitivity and reproducibility.
The YDL162C antibody can be effectively utilized for co-immunoprecipitation (Co-IP) studies to identify protein interaction networks. For optimal results:
Crosslinking: Consider using DSP (dithiobis[succinimidyl propionate]) or formaldehyde to stabilize transient interactions
Lysis conditions: Use gentle, non-denaturing buffers (e.g., 20 mM HEPES pH 7.4, 150 mM NaCl, 0.5% NP-40) supplemented with protease inhibitors
Pre-clearing: Incubate lysates with protein A/G beads to reduce non-specific binding
Antibody incubation: Use 2-5 μg antibody per 1 mg of total protein extract
Mass spectrometry analysis: Follow precipitation with proteomics analysis to identify binding partners
This approach facilitates comprehensive mapping of YDL162C's protein interaction network, providing insights into its cellular functions.
To effectively profile YDL162C expression under various stress conditions:
Stress parameters:
Heat shock: 37-42°C for 15-60 minutes
Nutrient deprivation: Growth in minimal media lacking specific nutrients
Oxidative stress: Treatment with H₂O₂ (0.1-5 mM)
Osmotic stress: Exposure to high salt (0.4-1.0 M NaCl)
Time-course analysis: Collect samples at multiple timepoints (0, 15, 30, 60, 120 minutes) after stress induction
Quantification methods:
Western blotting with densitometric analysis
qPCR for transcriptional changes
ELISA for precise protein quantification
Data normalization: Compare expression levels to established stress-response genes as internal controls
This systematic approach allows for comprehensive characterization of YDL162C's potential role in stress response pathways.
For precise subcellular localization of YDL162C using immunofluorescence:
Fixation method: Compare 4% paraformaldehyde with methanol fixation to determine optimal protocol
Permeabilization: Use 0.1-0.5% Triton X-100 for cell wall and membrane permeabilization
Blocking: Implement 3-5% BSA in PBS with 0.1% Tween-20 to minimize non-specific binding
Antibody dilution: Test range of 1:100-1:500 for primary antibody
Co-staining: Include organelle markers (nucleus, mitochondria, ER, Golgi) for precise localization
Z-stack imaging: Acquire multiple focal planes for three-dimensional reconstruction
Deconvolution: Apply appropriate algorithms to enhance resolution
These optimization steps enable precise determination of YDL162C's subcellular distribution under various conditions.
| Issue | Possible Causes | Solutions |
|---|---|---|
| No signal in Western blot | Insufficient protein extraction | Implement TCA extraction method |
| Protein degradation | Add complete protease inhibitor cocktail | |
| Inappropriate transfer conditions | Optimize transfer time and buffer composition | |
| High background | Non-specific binding | Increase blocking time/concentration |
| Excessive antibody concentration | Further dilute primary antibody | |
| Insufficient washing | Extend wash steps and increase Tween-20 concentration | |
| Multiple bands | Cross-reactivity | Validate with ΔYDL162C knockout control |
| Protein degradation | Add protease inhibitors, maintain samples at 4°C | |
| Poor reproducibility | Antibody stability issues | Prepare small aliquots, avoid freeze-thaw cycles |
| Inconsistent sample preparation | Standardize extraction protocol and protein quantification |
Systematic evaluation of these factors will help resolve technical challenges and improve experimental reproducibility .
To comprehensively validate the specificity of YDL162C antibody:
Genetic validation: Compare wildtype and ΔYDL162C knockout strains in Western blot and immunofluorescence applications
Immunodepletion: Pre-incubate antibody with purified recombinant YDL162C protein to confirm signal elimination
Mass spectrometry: Identify proteins in immunoprecipitated fractions to confirm target identity
Cross-reactivity assessment: Test antibody against other yeast species or mammalian systems where no reactivity is expected
Epitope mapping: Determine specific binding regions through peptide arrays or alanine scanning mutagenesis
These complementary approaches provide robust confirmation of antibody specificity, essential for reliable experimental interpretation.
When combining YDL162C antibody with proteomics techniques:
IP-MS workflow:
Use mild detergents (0.1-0.5% NP-40 or Digitonin) for cell lysis
Perform sequential elution to separate specific from non-specific interactions
Incorporate stable isotope labeling (SILAC) for quantitative interaction analysis
Chromatin immunoprecipitation (ChIP):
Optimize crosslinking conditions (1% formaldehyde, 10-15 minutes)
Ensure complete sonication to appropriate fragment size (200-500 bp)
Include input and IgG controls for normalization
Proximity labeling approaches:
These integrated approaches expand the utility of YDL162C antibody for comprehensive protein interaction studies.
While YDL162C antibody represents a conventional polyclonal approach, recent advances in antibody technology offer complementary methods:
Recombinant antibody production: Engineered antibody fragments (e.g., single-chain variable fragments, nanobodies) can provide enhanced specificity and reduced batch-to-batch variability compared to traditional polyclonal antibodies like anti-YDL162C
Antibody engineering approaches: Computational tools like DyAb (sequence-based antibody design) leverage machine learning to optimize antibody binding properties, potentially enhancing affinity beyond what is achievable with conventional polyclonal antibodies
Epitope-specific antibodies: Unlike polyclonal YDL162C antibody that recognizes multiple epitopes, newer monoclonal approaches provide epitope-specific recognition that can distinguish between different conformational states of proteins
Researchers should consider these complementary approaches based on their specific experimental requirements.
To fully characterize YDL162C function using the antibody:
CRISPR-based genetic manipulation:
Generate tagged variants for complementary detection methods
Create domain-specific deletions to map functional regions
Implement analog-sensitive mutations for temporal control
Quantitative interactomics:
Combine immunoprecipitation with mass spectrometry
Implement BioID proximity labeling for spatial interaction mapping
Apply crosslinking mass spectrometry for structural insights
High-throughput phenotypic analysis:
Integration of these methodologies provides a systems-level understanding of YDL162C's cellular functions and regulatory networks.